|
Age (mean, SD), years
|
62, 8.5
|
15
|
62, 8
|
1
|
|
Gender (n, %), male
|
84 (48%)
|
15
|
230 (46%)
|
1
|
|
Private Health Insurance (n, %)
|
108 (62%)
|
13
|
308 (61%)
|
0
|
|
Health Care Concession (n, %)
|
18 (10%)
|
13
|
56 (11%)
|
0
|
|
Co-morbidity with treatment (n,%)
|
|
Hypertension or Heart Disease
|
90 (52%)
|
15
|
213 (45%)
|
1
|
|
Ulcer or Stomach Disease
|
13 (7.5%)
|
15
|
46 (9%)
|
1
|
|
Kidney or Liver Disease
|
0 (0%)
|
15
|
4 (1%)
|
1
|
|
Symptom duration (≤5 years) (n, %)
|
92 (52%)
|
13
|
281 (56%)
|
0
|
|
WOMAC Pain (mean, sd)
|
4.1 (3.6)
|
0
|
4.2 (3.5)
|
0
|
|
WOMAC Physical (mean, sd)
|
15.9 (14.0)
|
0
|
17.0 (13.3)
|
0
|
|
Global assessment (mean (SD))
|
1.6 (1.0)
|
18
|
1.8 (1.1)
|
48
|
|
SF12 MCS (mean, SD)
|
52.7 (10.3)
|
13
|
53.5 (9.4)
|
0
|
|
SF12 PCS (mean, SD)
|
46.3 (9.4)
|
13
|
44.4 (9.5)
|
0
|
|
Glucosamine/chondroitin prior (n, %)
|
61 (35%)
|
13
|
154 (31%)
|
0
|
|
Current < daily/when required medication use
|
5 (3%)
|
13
|
38 (8%)*
|
0
|
|
Adherence (study treatment) < 100%a
|
86(53%)
|
3
|
N/Ab
|
N/Ab
|
|
Cost-related non-adherencea
|
19 (10%)
|
4
|
N/Ab
|
N/Ab
|
|
Physician Trusta (median, range)
|
75 (28–100)
|
0
|
N/Ab
|
N/Ab
|
